JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB119685

Anti-OPA1 antibody [1E81D9]

5

(1 Review)

|

(21 Publications)

Mouse Monoclonal OPA1 antibody. Suitable for Flow Cyt, WB and reacts with Human, Mouse, Rat samples. Cited in 21 publications.

View Alternative Names

KIAA0567, OPA1, Optic atrophy protein 1

2 Images
Flow Cytometry - Anti-OPA1 antibody [1E81D9] (AB119685)
  • Flow Cyt

Unknown

Flow Cytometry - Anti-OPA1 antibody [1E81D9] (AB119685)

Overlay histogram showing SH-SY5Y cells stained with ab119685 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab119685, 1μg/1x106 cells) for 30 min at 22°C. The secondary antibody used was Alexa Fluor® 488 goat anti-mouse IgG (H&L) (ab150113) at 1/2000 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG1 [ICIGG1] (ab91353, 1μg/1x106 cells) used under the same conditions. Unlabelled sample (blue line) was also used as a control. Acquisition of >5,000 events were collected using a 20mW Argon ion laser (488nm) and 525/30 bandpass filter.

Western blot - Anti-OPA1 antibody [1E81D9] (AB119685)
  • WB

Unknown

Western blot - Anti-OPA1 antibody [1E81D9] (AB119685)

All lanes:

Western blot - Anti-OPA1 antibody [1E81D9] (ab119685) at 1 µg/mL

Lane 1:

whole cell lysates from HeLa cells(human) at 30 µg

Lane 2:

whole cell lysates from H4IIE cells(rat) at 30 µg

Lane 3:

whole cell lysates from MEF cells(mouse) at 30 µg

Secondary

All lanes:

HRP goat anti-mouse at 1/5000 dilution

Predicted band size: 111 kDa

true

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

1E81D9

Isotype

IgG1

Light chain type

kappa

Carrier free

No

Reacts with

Mouse, Rat, Human

Applications

WB, Flow Cyt

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "ELISA" : {"fullname" : "ELISA", "shortname":"ELISA"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "1 µg for 10^6 Cells", "FlowCyt-species-notes": "<p><a href='/en-us/products/primary-antibodies/mouse-igg1-kappa-monoclonal-15-6e10a7-isotype-control-ab170190'>ab170190</a> - Mouse monoclonal IgG1, is suitable for use as an isotype control with this antibody.</p>", "ELISA-species-checked": "notRecommended", "ELISA-species-dilution-info": "", "ELISA-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1 µg/mL", "WB-species-notes": "<p></p>" }, "Mouse": { "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "FlowCyt-species-checked": "guaranteed", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "ELISA-species-checked": "notRecommended", "ELISA-species-dilution-info": "", "ELISA-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1 µg/mL", "WB-species-notes": "<p></p>" }, "Rat": { "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "FlowCyt-species-checked": "guaranteed", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "ELISA-species-checked": "notRecommended", "ELISA-species-dilution-info": "", "ELISA-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1 µg/mL", "WB-species-notes": "<p></p>" } } }

Product details

Want a custom formulation?
This antibody clone is manufactured by Abcam. If you require a custom buffer formulation or conjugation for your experiments, please contact orders@abcam.com

Properties and storage information

Form
Liquid
Purification technique
Precipitation Ammonium Sulphate
Purification notes
Purity is near homogeneity as judged by SDS-PAGE. ab119685 was produced in vitro using hybridomas grown in serum-free medium, and then concentrated by ammonium sulfate precipitation.
Storage buffer
pH: 7.5 Preservative: 0.02% Sodium azide Constituents: 99% HEPES buffered saline
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
Do Not Freeze

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

OPA1 also known as optic atrophy 1 is a dynamin-related GTPase protein important for mitochondrial fusion. OPA1 has a molecular weight of about 120 kDa and is present mostly in the inner mitochondrial membrane. It promotes the maintenance of mitochondrial DNA cristae structures and the modulation of mitochondrial dynamics. Expression of OPA1 occurs in tissues with high energy demands including the retina brain and muscles. Detection of the OPA1 protein can be done using techniques such as Western blot and it reveals different isoforms generated through alternative splicing.
Biological function summary

Mitochondrial dynamics involving OPA1 ensure energy production efficiency and cell health. OPA1 plays a role in mitochondrial fusion by forming a complex with mitofusins MFN1 and MFN2. This complex maintains the integrity of mitochondrial networks facilitates proper respiratory function and prevents apoptosis by regulating cristae junctions. It also participates in the stress response particularly in the preservation of the mitochondrial structure and function under challenging conditions.

Pathways

OPA1 integrates into the mitochondrial fusion and fission pathways important for cellular energy metabolism. It works alongside proteins like DRP1 in balancing these processes. The involvement in these pathways is essential for cellular adaptation to metabolic needs and stress. OPA1 also has a relationship with the PINK1/Parkin pathway where its regulation affects mitophagy a process of clearing damaged mitochondria. These interactions highlight the importance of OPA1 in maintaining cellular and mitochondrial homeostasis.

Mutations in OPA1 have been linked to autosomal dominant optic atrophy and a range of neurodegenerative conditions. The protein’s dysfunction leads to the degeneration of the retinal ganglion cells and their axons resulting in vision loss. OPA1 also shows connections to disorders like Charcot-Marie-Tooth disease where its interaction with other proteins like MFN2 plays a role. Deficiency or dysfunction of OPA1 disrupts mitochondrial dynamics leading to cellular energy deficits and contributing to disease pathophysiology.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Dynamin-related GTPase that is essential for normal mitochondrial morphology by mediating fusion of the mitochondrial inner membranes, regulating cristae morphology and maintaining respiratory chain function (PubMed : 16778770, PubMed : 17709429, PubMed : 20185555, PubMed : 24616225, PubMed : 28628083, PubMed : 28746876, PubMed : 31922487, PubMed : 32228866, PubMed : 32567732, PubMed : 33130824, PubMed : 33237841, PubMed : 37612504, PubMed : 37612506). Exists in two forms : the transmembrane, long form (Dynamin-like GTPase OPA1, long form; L-OPA1), which is tethered to the inner mitochondrial membrane, and the short soluble form (Dynamin-like GTPase OPA1, short form; S-OPA1), which results from proteolytic cleavage and localizes in the intermembrane space (PubMed : 31922487, PubMed : 32228866, PubMed : 33237841, PubMed : 37612504, PubMed : 37612506). Both forms (L-OPA1 and S-OPA1) cooperate to catalyze the fusion of the mitochondrial inner membrane (PubMed : 31922487, PubMed : 37612504, PubMed : 37612506). The equilibrium between L-OPA1 and S-OPA1 is essential : excess levels of S-OPA1, produced by cleavage by OMA1 following loss of mitochondrial membrane potential, lead to an impaired equilibrium between L-OPA1 and S-OPA1, inhibiting mitochondrial fusion (PubMed : 20038677, PubMed : 31922487). The balance between L-OPA1 and S-OPA1 also influences cristae shape and morphology (By similarity). Involved in remodeling cristae and the release of cytochrome c during apoptosis (By similarity). Proteolytic processing by PARL in response to intrinsic apoptotic signals may lead to disassembly of OPA1 oligomers and release of the caspase activator cytochrome C (CYCS) into the mitochondrial intermembrane space (By similarity). Acts as a regulator of T-helper Th17 cells, which are characterized by cells with fused mitochondria with tight cristae, by mediating mitochondrial membrane remodeling : OPA1 is required for interleukin-17 (IL-17) production (By similarity). Its role in mitochondrial morphology is required for mitochondrial genome maintenance (PubMed : 18158317, PubMed : 20974897).. Dynamin-like GTPase OPA1, long form. Constitutes the transmembrane long form (L-OPA1) that plays a central role in mitochondrial inner membrane fusion and cristae morphology (PubMed : 31922487, PubMed : 32228866, PubMed : 37612504, PubMed : 37612506). L-OPA1 and the soluble short form (S-OPA1) form higher-order helical assemblies that coordinate the fusion of mitochondrial inner membranes (PubMed : 31922487, PubMed : 37612504, PubMed : 37612506). Inner membrane-anchored L-OPA1 molecules initiate membrane remodeling by recruiting soluble S-OPA1 to rapidly polymerize into a flexible cylindrical scaffold encaging the mitochondrial inner membrane (PubMed : 37612504, PubMed : 37612506). Once at the membrane surface, the formation of S-OPA1 helices induce bilayer curvature (PubMed : 37612504, PubMed : 37612506). OPA1 dimerization through the paddle region, which inserts into cardiolipin-containing membrane, promotes GTP hydrolysis and the helical assembly of a flexible OPA1 lattice on the membrane, which drives membrane curvature and mitochondrial fusion (PubMed : 28628083, PubMed : 37612504, PubMed : 37612506). Plays a role in the maintenance and remodeling of mitochondrial cristae, some invaginations of the mitochondrial inner membrane that provide an increase in the surface area (PubMed : 32567732, PubMed : 33130824). Probably acts by forming helical filaments at the inside of inner membrane tubes with the shape and dimensions of crista junctions (By similarity). The equilibrium between L-OPA1 and S-OPA1 influences cristae shape and morphology : increased L-OPA1 levels promote cristae stacking and elongated mitochondria, while increased S-OPA1 levels correlated with irregular cristae packing and round mitochondria shape (By similarity).. Dynamin-like GTPase OPA1, short form. Constitutes the soluble short form (S-OPA1) generated by cleavage by OMA1, which plays a central role in mitochondrial inner membrane fusion and cristae morphology (PubMed : 31922487, PubMed : 32228866, PubMed : 32245890, PubMed : 37612504, PubMed : 37612506). The transmembrane long form (L-OPA1) and the S-OPA1 form higher-order helical assemblies that coordinate the fusion of mitochondrial inner membranes (PubMed : 31922487, PubMed : 32228866, PubMed : 37612504, PubMed : 37612506). Inner membrane-anchored L-OPA1 molecules initiate membrane remodeling by recruiting soluble S-OPA1 to rapidly polymerize into a flexible cylindrical scaffold encaging the mitochondrial inner membrane (PubMed : 32228866, PubMed : 37612504, PubMed : 37612506). Once at the membrane surface, the formation of S-OPA1 helices induce bilayer curvature (PubMed : 37612504, PubMed : 37612506). OPA1 dimerization through the paddle region, which inserts into cardiolipin-containing membrane, promotes GTP hydrolysis and the helical assembly of a flexible OPA1 lattice on the membrane, which drives membrane curvature and mitochondrial fusion (PubMed : 28628083, PubMed : 37612504, PubMed : 37612506). Excess levels of S-OPA1 produced by cleavage by OMA1 following stress conditions that induce loss of mitochondrial membrane potential, lead to an impaired equilibrium between L-OPA1 and S-OPA1, thereby inhibiting mitochondrial fusion (PubMed : 20038677). Involved in mitochondrial safeguard in response to transient mitochondrial membrane depolarization by mediating flickering : cleavage by OMA1 leads to excess production of S-OPA1, preventing mitochondrial hyperfusion (By similarity). Plays a role in the maintenance and remodeling of mitochondrial cristae, some invaginations of the mitochondrial inner membrane that provide an increase in the surface area (PubMed : 32245890). Probably acts by forming helical filaments at the inside of inner membrane tubes with the shape and dimensions of crista junctions (By similarity). The equilibrium between L-OPA1 and S-OPA1 influences cristae shape and morphology : increased L-OPA1 levels promote cristae stacking and elongated mitochondria, while increased S-OPA1 levels correlated with irregular cristae packing and round mitochondria shape (By similarity).. Isoform 1. Coexpression of isoform 1 with shorter alternative products is required for optimal activity in promoting mitochondrial fusion.. Isoform 4. Isoforms that contain the alternative exon 4b are required for mitochondrial genome maintenance, possibly by anchoring the mitochondrial nucleoids to the inner mitochondrial membrane.. Isoform 5. Isoforms that contain the alternative exon 4b are required for mitochondrial genome maintenance, possibly by anchoring the mitochondrial nucleoids to the inner mitochondrial membrane.
See full target information OPA1

Publications (21)

Recent publications for all applications. Explore the full list and refine your search

International journal of molecular medicine 56: PubMed40576133

2025

GW8510 alleviates muscle atrophy and skeletal muscle dysfunction in mice through AMPK/PGC1α signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Yutong Chen,Zurui Liu,Chen Liu,Daqian Yang,Mengmeng Xiao,Zhengqian Li,Zhengwei Xie

Frontiers in cardiovascular medicine 12:1506388 PubMed40486827

2025

Yellow Wine Polyphenolic Compounds protect against myocardial ischemia-reperfusion injury in rats by activating Nrf2 nuclear translocation to regulate the balance of mitochondrial fission and fusion.

Applications

Unspecified application

Species

Unspecified reactive species

Lili Xu,Jiedong Zhou,Haifei Lou,Haodi Gu,Haixia Xu,Zuoquan Zhong,Hui Lin,Chengjian Jiang

Nature communications 16:5261 PubMed40480980

2025

TANGO2 binds crystallin alpha B and its loss causes desminopathy.

Applications

Unspecified application

Species

Unspecified reactive species

Maike Stentenbach,Laetitia A Hughes,Samuel V Fagan,Blake Payne,Danielle L Rudler,Stefan J Siira,Tim McCubbin,Anaëlle Chopin,Kara L Perks,Judith A Ermer,James Hendry,Teagan S Er,Shanti Balasubramaniam,Joel A Eliades,Livia C Hool,Nicolle H Packer,Edward S X Moh,Benjamin S Padman,Oliver Rackham,Aleksandra Filipovska

Physiological reports 13:e70371 PubMed40356314

2025

Chronic stress elicits sex-specific mitochondrial respiratory functional changes in the rat heart.

Applications

Unspecified application

Species

Unspecified reactive species

Caitlin P Odendaal-Gambrell,Cassidy O'Brien,Megan Cairns,Gerald J Maarman,Danzil E Joseph,Carine Smith,Fanie Rautenbach,Jeanine L Marnewick,M Faadiel Essop

The Journal of physiology 603:3725-3753 PubMed39792484

2025

Previous short-term disuse dictates muscle gene expression and physiological adaptations to subsequent resistance exercise.

Applications

Unspecified application

Species

Unspecified reactive species

Martino V Franchi,Julián Candia,Fabio Sarto,Giuseppe Sirago,Giacomo Valli,Matteo Paganini,Lisa Hartnell,Emiliana Giacomello,Luana Toniolo,Elena Monti,Leonardo Nogara,Tatiana Moro,Antonio Paoli,Marta Murgia,Lorenza Brocca,Maria Antonietta Pellegrino,Bruno Grassi,Roberto Bottinelli,Giuseppe De Vito,Luigi Ferrucci,Marco V Narici

Molecular medicine (Cambridge, Mass.) 30:222 PubMed39563263

2024

FUT8 upregulates CD36 and its core fucosylation to accelerate pericyte-myofibroblast transition through the mitochondrial-dependent apoptosis pathway during AKI-CKD.

Applications

Unspecified application

Species

Unspecified reactive species

Yaxi Shang,Ziran Wang,Fan Yang,Weidong Wang,Qingzhu Tang,Xianan Guo,Xiangning Du,Xu Zhang,Jiaojiao Hao,Hongli Lin

Cells 12: PubMed36766738

2023

Effect of Thyroxine on the Structural and Dynamic Features of Cardiac Mitochondria and Mitophagy in Rats.

Applications

Unspecified application

Species

Unspecified reactive species

Natalya Venediktova,Ilya Solomadin,Vlada Starinets

International journal of environmental research and public health 20: PubMed36674144

2023

Gestational Exercise Antagonises the Impact of Maternal High-Fat High-Sucrose Diet on Liver Mitochondrial Alterations and Quality Control Signalling in Male Offspring.

Applications

Unspecified application

Species

Unspecified reactive species

Jelena Stevanović-Silva,Jorge Beleza,Pedro Coxito,Paulo J Oliveira,António Ascensão,José Magalhães

Journal of cellular and molecular medicine 26:3702-3715 PubMed35650472

2022

Matrine alleviates cisplatin-induced acute kidney injury by inhibiting mitochondrial dysfunction and inflammation via SIRT3/OPA1 pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Lu Yuan,Jingchao Yang,Ying Li,Longhui Yuan,Fei Liu,Yujia Yuan,Xiaochi Tang

Acta pharmacologica Sinica 43:2651-2665 PubMed35217814

2022

Anti-diabetic drug canagliflozin hinders skeletal muscle regeneration in mice.

Applications

Unspecified application

Species

Unspecified reactive species

Xin-Huang Lv,Xiao-Xia Cong,Jin-Liang Nan,Xing-Mei Lu,Qian-Li Zhu,Jian Shen,Bei-Bei Wang,Zhi-Ting Wang,Ri-Yong Zhou,Wei-An Chen,Lan Su,Xiao Chen,Zheng-Zheng Li,Yi-Nuo Lin
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com